GRACE LLEWELLYN: Open Payments
NPI 1972068674 · LIBERTY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 15 payments from 9 companies in 2025. Trend: 2023 $938 · 2024 $1,217 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $71 |
| Kowa Pharmaceuticals America, Inc. | 3 | $47 |
| Lilly USA, LLC | 2 | $38 |
| ABBVIE INC. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: ZORYVE, KISUNLA, QULIPTA, MOUNJARO, Veozah, AIRSUPRA, AZMIRO, OTEZLA.
Industry payments across MO — which companies pay providers there.
